References
- Vose J, Armitage J, Weisenburger D. International peripheral T-cell and natural killer/T-cell lymphoma study: pathology findings and clinical outcomes. J Clin Oncol 2008;26:4124–4130.
- Iqbal J, Weisenburger DD, Greiner TC, et al Molecular signatures to improve diagnosis in peripheral T-cell lymphoma and prognostication in angioimmunoblastic T-cell lymphoma. Blood 2010;115:1026–1036.
- Swerdlow S, Campo E, Harris N, et al WHO classification of tumours of the haematopoietic and lymphoid tissues. 4th ed. Lyon: IARC; 2008.
- Gallamini A, Stelitano C, Calvi R, et al Peripheral T-cell lymphoma unspecified (PTCL-U): a new prognostic model from a retrospective multicentric clinical study. Blood 2004;103:2474–2479.
- Hasenclever D, Diehl V. A prognostic score for advanced Hodgkin's disease. International Prognostic Factors Project on Advanced Hodgkin's Disease. N Engl J Med 1998;339:1506–1514.
- Ray-Coquard I, Cropet C, Van Glabbeke M, et al Lymphopenia as a prognostic factor for overall survival in advanced carcinomas, sarcomas, and lymphomas. Cancer Res 2009;69:5383–5391.
- Went P, Agostinelli C, Gallamini A, et al Marker expression in peripheral T-cell lymphoma: a proposed clinical-pathologic prognostic score. J Clin Oncol 2006;24:2472–2479.
- Blay JY, Chauvin F, Le Cesne A, et al Early lymphopenia after cytotoxic chemotherapy as a risk factor for febrile neutropenia. J Clin Oncol 1996;14:636–643.
- Talaulikar D, Choudhury A, Shadbolt B, et al Lymphocytopenia as a prognostic marker for diffuse large B cell lymphomas. Leuk Lymphoma 2008;49:959–964.
- Lachenal F, Berger F, Ghesquieres H, et al Angioimmunoblastic T-cell lymphoma: clinical and laboratory features at diagnosis in 77 patients. Medicine (Baltimore) 2007;86:282–292.
- Bierman PJ, Lynch JC, Bociek RG, et al The International Prognostic Factors Project score for advanced Hodgkin's disease is useful for predicting outcome of autologous hematopoietic stem cell transplantation. Ann Oncol 2002;13:1370–1377.
- Ayoub JP, Palmer JL, Huh Y, et al Therapeutic and prognostic implications of peripheral blood lymphopenia in patients with Hodgkin's disease. Leuk Lymphoma 1999;34:519–527.
- Kim DH, Baek JH, Chae YS, et al Absolute lymphocyte counts predicts response to chemotherapy and survival in diffuse large B-cell lymphoma. Leukemia 2007;21:2227–3220.
- Oki Y, Yamamoto K, Kato H, et al Low absolute lymphocyte count is a poor prognostic marker in patients with diffuse large B-cell lymphoma and suggests patients' survival benefit from rituximab. Eur J Haematol 2008;81:448–453.
- Song MK, Chung JS, Seol YM, et al Influence of low absolute lymphocyte count of patients with nongerminal center type diffuse large B-cell lymphoma with R-CHOP therapy. Ann Oncol 2010;21:140–144.
- De Angulo G, Yuen C, Palla SL, et al Absolute lymphocyte count is a novel prognostic indicator in ALL and AML: implications for risk stratification and future studies. Cancer 2008;112:407–415.
- Ege H, Gertz MA, Markovic SN, et al Prediction of survival using absolute lymphocyte count for newly diagnosed patients with multiple myeloma: a retrospective study. Br J Haematol 2008;141:792–798.
- Porrata LF, Markovic SN. Timely reconstitution of immune competence affects clinical outcome following autologous stem cell transplantation. Clin Exp Med 2004;4:78–85.
- Siddiqui M, Ristow K, Markovic SN, et al Absolute lymphocyte count predicts overall survival in follicular lymphomas. Br J Haematol 2006;134:596–601.
- Plonquet A, Haioun C, Jais JP, et al Peripheral blood natural killer cell count is associated with clinical outcome in patients with aaIPI 2-3 diffuse large B-cell lymphoma. Ann Oncol 2007;18:1209–1215.
- Kitagawa J, Hara T, Tsurumi H, et al Serum-soluble interleukin-2 receptor (sIL-2R) is an extremely strong prognostic factor for patients with peripheral T-cell lymphoma, unspecified (PTCL-U). J Cancer Res Clin Oncol 2009;135:53–59.
- Ishida T, Inagaki H, Utsunomiya A, et al CXC chemokine receptor 3 and CC chemokine receptor 4 expression in T-cell and NK-cell lymphomas with special reference to clinicopathological significance for peripheral T-cell lymphoma, unspecified. Clin Cancer Res 2004;10:5494–5500.
- Chihara D, Oki Y, Ine S, et al Analysis of prognostic factors in peripheral T-cell lymphoma: prognostic value of serum albumin and mediastinal lymphadenopathy. Leuk Lymphoma 2009;50:1999–2004.